---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278599665.md"
description: "Esperion shares are trading lower after the company reported worse-than-expected Q4 financial results."
datetime: "2026-03-10T18:03:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278599665.md)
  - [en](https://longbridge.com/en/news/278599665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278599665.md)
---

# 

Esperion shares are trading lower after the company reported worse-than-expected Q4 financial results.

### Related Stocks

- [ESPR.US](https://longbridge.com/en/quote/ESPR.US.md)

## Related News & Research

- [Esperion Therapeutics Highlights 38% Revenue Growth, Enbumyst Launch Plan at Needham Conference](https://longbridge.com/en/news/282600951.md)
- [Esperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio](https://longbridge.com/en/news/281578871.md)
- [Esperion Insiders Quietly Cash Out as Top Executives Trim Their Stakes](https://longbridge.com/en/news/279718023.md)
- [Esperion Therapeutics Q4 Earnings Call Highlights](https://longbridge.com/en/news/278573800.md)
- [Esperion Therapeutics Touts 38% Revenue Growth, Corstasis Deal and 2026 Cash-Gen Path at Conference](https://longbridge.com/en/news/279175638.md)